Hospitalization – Page 23 – Communicable Diseases Research

Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial

Article

Published on 2022-09-202022-11-16
Journal: Trials [Category] SARS, 변종,

Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial

Article

Published on 2022-09-172022-10-06
Journal: EClinicalMedicine [Category] 진단,

[키워드] 1:1 95 % CI Activation addition Administered adverse event approach assigned Basel blockade BMI canakinumab Clinical outcome contributing to COVID-19 CRP Dexamethasone diabetes died dose double-blind dropped drug Efficacy foundation glycaemic control higher risk hospitalised Hospitalization Hyperinflammatory ICU IL-1beta IL-1β IL-6 IMPROVE Inflammasome innate immune system interleukin-1β intravenous dose less medication multicenter multicentre Novartis Obesitiy. obesity outcome participant Patient patients treated patients with COVID-19 Placebo placebo group placebo-controlled trial primary analysis randomised randomization Randomly reduction Registered reported required SARS-CoV2 SARS-CoV2 infection Science Seven severe COVID-19 significantly Standard-of-care statistically significant statistically significant difference survival Switzerland systemic inflammation tested treated Treatment type 2 diabete university Ventilation with COVID-19
[DOI] 10.1016/j.eclinm.2022.101649 PMC 바로가기 [Article Type] Article

Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE

Article

Published on 2022-09-172022-11-16
Journal: Journal of Travel Medicine [Category] Fulltext, MERS, 변종,

Evaluating the Factors Affecting COVID-19 Patients’ Mortality in Arak in 2020

Article

Published on 2022-09-162022-11-15
Journal: Canadian Respiratory Journal [Category] SARS, 치료제,

[키워드] Acute kidney injury acute respiratory distress Admission affected age AKI Antibiotic therapy Antiviral arrhythmia blood pressure C-reactive protein cardiovascular disease cause Complication coronavirus disease Course COVID-19 creatine phosphokinase creatinine D-dimer death Diabetes Mellitus disease Disease progression elevated Evaluating expired Factor ferritin hemoglobin Hospitalization intensive care International investigated Laboratory lactate dehydrogenase liver enzyme Lung disease Lymphocytes Mortality Myocardial infarction normalized occur onset of symptom oxygen saturation pandemic patients Prevent Prothrombin time recovered patient risk factor Risk factors Sepsis syndrome Tachycardia tachypnea the disease two group underlying diseases White blood cell
[DOI] 10.1155/2022/9594931 PMC 바로가기

Assessing COVID-19 vaccination strategies in varied demographics using an individual-based model

Article

Published on 2022-09-152022-11-15
Journal: Frontiers in Public Health [Category] SARS, 변종, 치료기술, 치료제,

[키워드] age agent-based model (ABM) applied Assessing asymptomatic infections booster doses Characteristics Contact COVID COVID- 19 COVID-19 COVID-19 vaccination COVID-19 vaccine demographics distribution distributions Effectiveness Efficiency help Hospitalization household size individual individual-base model Infection infection rate Intervention New non-pharmaceutical interventions (NPIs) NPI NPIs outbreak parameter Prevent Probability reproductive responses against SARS-CoV-2 severe disease structures subpopulation symptomatic Total unique vaccinate vaccination Vaccination strategies Vaccination strategy variants variants of SARS-CoV-2
[DOI] 10.3389/fpubh.2022.966756 PMC 바로가기

Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults

Article

Published on 2022-09-142022-11-15
Journal: Journal of Virology [Category] SARS, 변종, 진단,

[키워드] Adolescent adolescents adolescents and adult adolescents and adults Adults age antibody Antibody binding antibody binding titers approved Beta binding binding antibody BNT162b2 BNT162b2 vaccine booster booster dose booster vaccination breadth changes in children circulating clinical trial Cohort Coverage COVID-19 Delta demonstrated dose drug Effectiveness Efficacy evaluate FDA food Gamma highlight Hospitalization humoral immune response lack less Loss magnitude mounted mRNA vaccine neutralization Neutralizing antibody response omicron Omicron (B.1.1.529) pandemic pediatric Pfizer Pfizer-BioNTech Pfizer-BioNTech (BNT162b2) plasma populations PROTECT reduction reported Research response responses against robust SARS-CoV-2 seasonal beta coronavirus the antibody response the SARS-CoV-2 the vaccine vaccination Vaccine vaccine-induced antibody response Vaccine-induced immunity variant variant of concerns (VOCs) variants viral variant Virus neutralization virus spike protein VoC VOCs while wild-type SARS-CoV-2
[DOI] 10.1128/jvi.00582-22 PMC 바로가기

The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection

Article

Published on 2022-09-142022-11-15
Journal: Journal of Virology [Category] SARS, 변종, 치료기술,

[키워드] addition B.1 B.1.1.529 B.1.617.2 body temperature cats clinical COVID-19 D614G death Delta delta variant disease severity distribution effective Evidence evidenced histologic Hospitalization immunization immunofluorescence increased risk Infection infections Infectious virus Inflammation inoculated less lethargic log Lower lung Lung pathology Mild Model mutated nasal nasal turbinate observation omicron Pathogenesis pathogenic pathogenicity Pneumonia Postinfection present reduced remained Replication SARS-CoV-2 SARS-CoV-2 D614G SARS-CoV-2 variant secretion significant increase South Africa Spread staining suggested susceptible TCID tissue tissue tropism variant variant of concern variants Viral load viral replication Viral RNA viral titer Viral variants Virological virulence virus
[DOI] 10.1128/jvi.00961-22 PMC 바로가기

Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron

Article

Published on 2022-09-132022-11-15
Journal: Immunity [Category] SARS, 변종, 진단,

SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria

Article

Published on 2022-09-092022-11-16
Journal: PLoS ONE [Category] SARS, 변종,

SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era

Article

Published on 2022-09-082022-11-16
Journal: Virology Journal [Category] SARS, 변종,

[키워드] Affect Asymptomatic available data B.1.1.529 B.1.617.2 caused children clinical manifestation clinical manifestations Complication conditions coronavirus disease country COVID-19 Delta delta variant Direct drastic exacerbating Google Scholar Health highest highlight Hospitalization immune response Immunodepressive incidence Infant Infants infected children Infection Manifestations Mild MIS MIS-C occur omicron Omicron variant pandemic pediatric Prevalence prevalence of COVID-19 proportion reported Risk factors SARS-COV-2 infection Science suggested symptomatic SARS-CoV-2 infection Symptoms the United State Transmission dynamics vaccination variant variants virulent
[DOI] 10.1186/s12985-022-01873-4 PMC 바로가기